Cook, Michael R.
Dunleavy, Kieron
Article History
Accepted: 13 February 2022
First Online: 11 April 2022
Declarations
:
: This article does not contain any studies with human or animal subjects performed by any of the authors.
: Michael Cook declares no conflict of interest. Kieron Dunleavy has participated on advisory boards for Astra Zeneca, Beigene, Genmab, Abbvie, Morphosys, Daiichi Sankyo, Genentech and ADC Therapeutics.